{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:19:16Z","timestamp":1787948356037,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Research Project of Henan Province","award":["No.242102310548"],"award-info":[{"award-number":["No.242102310548"]}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project of the Ministry of Science and Technology of China","doi-asserted-by":"crossref","award":["No.2023ZD0505703"],"award-info":[{"award-number":["No.2023ZD0505703"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhongyuan Leading Talents Program of Science and Technology Innovation","award":["No. 244200510002"],"award-info":[{"award-number":["No. 244200510002"]}]},{"name":"Joint Fund for Science and Technology Research and Development Program of Henan Province","award":["No.232301420021 and No.242301420108"],"award-info":[{"award-number":["No.232301420021 and No.242301420108"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["No. 242300420109"],"award-info":[{"award-number":["No. 242300420109"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Major Research Project of National Traditional Chinese Medicine Inheritance and Innovation Center, Henan Provincial Health Commission","award":["No. 2024ZXZX1015"],"award-info":[{"award-number":["No. 2024ZXZX1015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05166-w","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:16:39Z","timestamp":1758878199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between fibrosis-4 index and coronary heart disease: a population-based study"],"prefix":"10.1186","volume":"25","author":[{"given":"Pan","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamajan","family":"Annamyradova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yankun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaozhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"25","key":"5166_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. GBD-NHLBI-JACC global burden of cardiovascular diseases writing group. global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"10258","key":"5166_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"8","key":"5166_CR3","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","volume":"149","author":"SS Martin","year":"2024","unstructured":"Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2024 heart disease and stroke statistics: A report of US and global data from the American heart association. Circulation. 2024;149(8):e347\u2013913.","journal-title":"Circulation"},{"issue":"13","key":"5166_CR4","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1007\/s11606-021-07341-z","volume":"37","author":"AD Schreiner","year":"2022","unstructured":"Schreiner AD, Moran WP, Zhang J, Livingston S, Marsden J, Mauldin PD, et al. The association of Fibrosis-4 index scores with severe liver outcomes in primary care. J Gen Intern Med. 2022;37(13):3266\u201374.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"5166_CR5","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797\u2013835.","journal-title":"Hepatology"},{"issue":"5","key":"5166_CR6","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal F, Shubrook JH, Adams LA, Pfotenhauer K, Wai-Sun Wong V, Wright E, et al. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterology. 2021;161(5):1657\u201369.","journal-title":"Gastroenterology"},{"issue":"5","key":"5166_CR7","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264\u201381.","journal-title":"Gastroenterology"},{"issue":"4","key":"5166_CR8","first-page":"1080","volume":"165","author":"JJ Wattacheril","year":"2023","unstructured":"Wattacheril JJ, Abdelmalek MF, Lim JK, Sanyal AJ. AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease. Expert Rev Gastroenterol. 2023;165(4):1080\u20138.","journal-title":"Expert Rev Gastroenterol"},{"issue":"13","key":"5166_CR9","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1016\/j.cgh.2023.04.026","volume":"21","author":"YG Seo","year":"2023","unstructured":"Seo YG, Polyzos SA, Park KH, Mantzoros CS. Fibrosis-4 index predicts long-term all-cause, cardiovascular and liver-related mortality in the adult Korean population. Clin Gastroenterol Hepatol. 2023;21(13):3322\u201335.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5166_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2020.03.010","volume":"299","author":"Q Chen","year":"2020","unstructured":"Chen Q, Li Q, Li D, Chen X, Liu Z, Hu G, et al. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease. Atherosclerosis. 2020;299:45\u201352.","journal-title":"Atherosclerosis"},{"issue":"15","key":"5166_CR11","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.3390\/nu14153163","volume":"14","author":"TY Tsai","year":"2022","unstructured":"Tsai TY, Hsu PF, Wu CH, Huang SS, Chan WL, Lin SJ, et al. Association between coronary artery plaque progression and liver fibrosis biomarkers in population with low calcium scores. Nutrients. 2022;14(15):3163.","journal-title":"Nutrients"},{"issue":"8","key":"5166_CR12","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/ATVBAHA.111.228262","volume":"31","author":"CE Ndumele","year":"2011","unstructured":"Ndumele CE, Nasir K, Concei\u00e7ao RD, Carvalho JA, Blumenthal RS, Santos RD. Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation. Arterioscler Thromb Vasc Biol. 2011;31(8):1927\u201332.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"5166_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12933-023-01965-7","volume":"22","author":"Y An","year":"2023","unstructured":"An Y, Xu BT, Wan SR, Ma XM, Long Y, Xu Y, et al. The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovasc Diabetol. 2023;22(1):237.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5166_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2486594","volume":"57","author":"Z Gui","year":"2025","unstructured":"Gui Z, Chen X, Wang D, Chen Z, Liu S, Yu G, et al. Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk. Ann Med. 2025;57(1):2486594.","journal-title":"Ann Med"},{"issue":"1","key":"5166_CR15","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1016\/j.ijcard.2013.12.265","volume":"172","author":"H Hamasaki","year":"2014","unstructured":"Hamasaki H, Yanai H. An absence of atherosclerosis progression in a type 2 diabetic patient with multiple atherosclerotic risk factors, complicated with liver cirrhosis. Int J Cardiol. 2014;172(1):e253-4.","journal-title":"Int J Cardiol"},{"issue":"19","key":"5166_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910595","volume":"25","author":"N Ktenopoulos","year":"2024","unstructured":"Ktenopoulos N, Sagris M, Gerogianni M, Pamporis K, Apostolos A, Balampanis K, et al. Non-alcoholic fatty liver disease and coronary artery disease: a bidirectional association based on endothelial dysfunction. Int J Mol Sci. 2024;25(19):10595.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5166_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12072-021-10167-w","volume":"15","author":"JL Jin","year":"2021","unstructured":"Jin JL, Zhang HW, Cao YX, Liu HH, Hua Q, Li YF, et al. Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease. Hepatol Int. 2021;15(2):413\u201323.","journal-title":"Hepatol Int"},{"issue":"12","key":"5166_CR18","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00392-022-02055-6","volume":"111","author":"M Sudo","year":"2022","unstructured":"Sudo M, Shamekhi J, Sedaghat A, Aksoy A, Zietzer A, Tanaka T, et al. Predictive value of the Fibrosis-4 index in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Clin Res Cardiol. 2022;111(12):1367\u201376.","journal-title":"Clin Res Cardiol"},{"key":"5166_CR19","doi-asserted-by":"crossref","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","DOI":"10.1002\/hep.21178"},{"key":"5166_CR20","doi-asserted-by":"publisher","first-page":"e2018150","DOI":"10.1001\/jamanetworkopen.2020.18150","volume":"3","author":"SM Abdalla","year":"2020","unstructured":"Abdalla SM, Yu S, Galea S. Trends in cardiovascular disease prevalence by income level in the united States. JAMA Netw Open. 2020;3:e2018150.","journal-title":"JAMA Netw Open"},{"key":"5166_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijcard.2018.01.046","volume":"259","author":"TG Simon","year":"2018","unstructured":"Simon TG, Trejo MEP, McClelland R, Bradley R, Blaha MJ, Zeb I, et al. Circulating interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis. Int J Cardiol. 2018;259:198\u2013204.","journal-title":"Int J Cardiol"},{"issue":"2","key":"5166_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/FJC.0000000000000642","volume":"73","author":"J Ma","year":"2019","unstructured":"Ma J, Zhao D, Wang X, Ma C, Feng K, Zhang S, et al. Longshengzhi capsule reduces established atherosclerotic lesions in apoE-deficient mice by ameliorating hepatic lipid metabolism and inhibiting inflammation. J Cardiovasc Pharmacol. 2019;73(2):105\u201317.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"5166_CR23","doi-asserted-by":"publisher","first-page":"2486594","DOI":"10.1080\/07853890.2025.2486594","volume":"57","author":"Z Gui","year":"2025","unstructured":"Gui Z, Chen X, Wang D, Chen Z, Liu S, Yu G, et al. Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk. Ann Med. 2025 Dec;57(1):2486594.","journal-title":"Ann Med."},{"key":"5166_CR24","unstructured":"Eslam M, Fan JG, Yu ML, Wong VW, Cua IH, Liu CJ, et al. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease. Hepatol Int. 2025 Apr;19(2):261-301.\u00a0"},{"key":"5166_CR25","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/j.redox.2020.101775","volume":"38","author":"M Zhang","year":"2021","unstructured":"Zhang M, Gao J, Zhao X, Zhao M, Ma D, Zhang X, et al. p38\u03b1 in macrophages aggravates arterial endothelium injury by releasing IL-6 through phosphorylating megakaryocytic leukemia 1. Redox Biol. 2021 Jan;38:101775.","journal-title":"Redox Biol."},{"issue":"1","key":"5166_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/hep.27382","volume":"61","author":"G Xiao","year":"2015","unstructured":"Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2015 Jan;61(1):292-302.","journal-title":"Hepatology."},{"key":"5166_CR27","doi-asserted-by":"crossref","unstructured":"Han JW, Kim HY, Yu JH, Kim MN, Chon YE, An JH, et al. Diagnostic accuracy of the Fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: A systematic review and meta-analysis. Clin Mol Hepatol. 2024 Sep;30(Suppl):S147-S158.","DOI":"10.3350\/cmh.2024.0330"},{"key":"5166_CR28","doi-asserted-by":"crossref","unstructured":"Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol. 2018;19:654\u201372.","DOI":"10.1038\/s41580-018-0044-8"},{"key":"5166_CR29","doi-asserted-by":"crossref","unstructured":"YTakeshima R, Kamata M, Suzuki S, Ito M, Watanabe A, Uchida H, et al. Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitors. J Dermatol. 2024 Sep;51(9):1216-1224.","DOI":"10.1111\/1346-8138.17277"},{"key":"5166_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","volume":"22","author":"P Roy","year":"2022","unstructured":"Roy P, Orecchioni M, Ley K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nat Rev Immunol. 2022;22:251\u201365.","journal-title":"Nat Rev Immunol."},{"key":"5166_CR31","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41419-023-06206-z","volume":"14","author":"P Hou","year":"2023","unstructured":"Hou P, Fang J, Liu Z, Shi Y, Agostini M, Bernassola F, et al. Macrophage polarization and metabolism in atherosclerosis. Cell Death Dis. 2023;14:691.","journal-title":"Cell Death Dis."},{"key":"5166_CR32","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-P\u00e9rez AM, Ruiz-Lim\u00f3n P, Salas-Salvad\u00f3 J, Vioque J, Corella D, Fit\u00f3 M, et al. Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis. Gut Microbes. 2023 Jan-Dec;15(1):2223339.","DOI":"10.1080\/19490976.2023.2223339"},{"issue":"5","key":"5166_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ejheart.2003.12.008","volume":"6","author":"C Denis","year":"2004","unstructured":"Denis C, De Kerguennec C, Bernuau J, Beauvais F, Cohen Solal A. Acute hypoxic hepatitis ('liver shock'): still a frequently overlooked cardiological diagnosis. Eur J Heart Fail. 2004 Aug;6(5):561-5.","journal-title":"Eur J Heart Fail."},{"issue":"7","key":"5166_CR34","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.healun.2014.12.009","volume":"34","author":"M Farr","year":"2015","unstructured":"Farr M, Mitchell J, Lippel M, Kato TS, Jin Z, Ippolito P, et al. Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction. J Heart Lung Transplant. 2015 Jul;34(7):873-82.","journal-title":"J Heart Lung Transplant."},{"key":"5166_CR35","doi-asserted-by":"crossref","unstructured":"Namakchian M, Rabizadeh S, Seifouri S, Asadigandomani H, Bafrani MA, Seifouri K, et al. Fibrosis score 4 index has an independent relationship with coronary artery diseases in patients with metabolic-associated fatty liver disease. Diabetol Metab Syndr. 2023 Mar 25;15(1):57.","DOI":"10.1186\/s13098-023-01031-y"},{"key":"5166_CR36","doi-asserted-by":"crossref","unstructured":"Ye Z, Xie E, Guo Z, Gao Y, Han Z, Dou K, et al. Association of Liver Fibrosis Markers with Mortality Outcomes in Patients with Chronic Kidney Disease and Coronary Artery Disease: Insights from the NHANES 1999-2018 Data. Cardiorenal Med. 2025;15(1):153-163.\u00a0","DOI":"10.1159\/000543500"},{"key":"5166_CR37","doi-asserted-by":"crossref","unstructured":"McNally BB, Rangan P, Wijarnpreecha K, Fallon MB. Fibrosis-4 Index Score Predicts Concomitant Coronary Artery Diseases Across the Spectrum of Fatty Liver Disease. Dig Dis Sci. 2023 Sep;68(9):3765-3773.","DOI":"10.1007\/s10620-023-07987-1"},{"key":"5166_CR38","doi-asserted-by":"crossref","unstructured":"Vieira Barbosa J, Milligan S, Frick A, Broestl J, Younossi Z, Afdhal N, et al. Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease. Am J Gastroenterol. 2022 Mar 1;117(3):453-461.","DOI":"10.14309\/ajg.0000000000001606"},{"issue":"3","key":"5166_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/biom14030309","volume":"14","author":"R Licordari","year":"2024","unstructured":"Licordari R, Correale M, Bonanno S, Beltrami M, Ciccarelli M, Micari A, et al. Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure. Biomolecules. 2024 Mar 6;14(3):309.\u00a0","journal-title":"Biomolecules."},{"key":"5166_CR40","doi-asserted-by":"crossref","unstructured":"Andersen CJ, Fernandez ML. Emerging Biomarkers and Determinants of Lipoprotein Profiles to Predict CVD Risk: Implications for Precision Nutrition. Nutrients. 2024 Dec 27;17(1):42.","DOI":"10.3390\/nu17010042"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05166-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05166-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05166-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:16:45Z","timestamp":1758878205000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05166-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5166"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05166-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES study protocol received approval from the National Center for Health Statistics Institutional Review Board, with all participants providing written informed consent in compliance with institutional and regulatory requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"668"}}